Horizon Bancorp’s Avanos Medical AVNS Stock Holding History

Horizon Bancorp’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-16	Closed	–	–	242
2023 Q3	$0	Hold	16	–	–	﹤0.01%	240
2023 Q2	$1K	Hold	16	–	–	﹤0.01%	222
2023 Q1	$0	Buy	+16	New	+$465	﹤0.01%	182

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Horizon Bancorp's AVNS Position: Q4 2023 in Review

Horizon Bancorp sold out of Avanos Medical (AVNS) in Q4 2023, closing a stake of 16 shares.

Horizon Bancorp first reported a position in AVNS in Q1 2023 and held it in 3 quarters. The position peaked at $1K in Q2 2023. 265 funds tracked by Wall St. Rank hold AVNS as of Q4 2023.

Horizon Bancorp reported no remaining Avanos Medical position as of Q4 2023 after selling out during the quarter.
Horizon Bancorp sold 16 Avanos Medical shares in Q4 2023.
Horizon Bancorp first reported a position in Avanos Medical in Q1 2023 and held it in 3 quarters.
Horizon Bancorp's Avanos Medical position peaked at $1K in Q2 2023.
265 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2023.

Based on Horizon Bancorp's 13F filing for Q4 2023, filed 16 Jan 2024.